Daniel Barber (AQST) files Form 144 to sell 25K Aquestive shares

Rhea-AI Filing Summary

Daniel R. Barber submitted a notice relating to Aquestive Therapeutics (AQST) common stock, indicating an intention to sell 25,000 shares through Morgan Stanley Smith Barney LLC on or after 07/15/2026 on NASDAQ. These shares trace to 25,000 Restricted Stock Units acquired from the issuer on 03/09/2024. Over the prior three months, transactions labeled as 10b5-1 Sales show sales of 25,000 shares on 06/15/2026 and 8,257 shares on 05/15/2026, for amounts of 104010.00 and 35413.45, respectively.

Key Figures

Planned shares to be sold: 25,000 shares Planned aggregate market value: 101000.00 RSUs acquired: 25,000 units +2 more

5 metrics

Planned shares to be sold 25,000 shares Common stock to be sold through Morgan Stanley Smith Barney LLC on or after 07/15/2026

Planned aggregate market value 101000.00 Value associated with 25,000 shares of AQST common stock listed in the Form 144

RSUs acquired 25,000 units Restricted Stock Units acquired from the issuer on 03/09/2024

Recent 10b5-1 sale 1 25,000 shares; 104010.00 Common shares sold on 06/15/2026 in a transaction labeled as 10b5-1 Sales

Recent 10b5-1 sale 2 8,257 shares; 35413.45 Common shares sold on 05/15/2026 in a transaction labeled as 10b5-1 Sales

Key Terms

Form 144, Restricted Stock Units, 10b5-1 Sales, aggregate market value

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Common | 03/09/2024 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for DANIEL R BARBER 30 Technology Drive"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

aggregate market value financial

"25000 | 101000.00 | 125450119 | 07/15/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/15/2026 - 04:38 PM Accepted by SEC EDGAR 07/15/2026 - 04:37 PM Learn about SEC filing dates

FAQ

How many AQST shares does Daniel R. Barber plan to sell under this Form 144?

The filing indicates a planned sale of 25,000 shares of Aquestive Therapeutics (AQST) common stock. The sale is expected to be executed through Morgan Stanley Smith Barney LLC on or after 07/15/2026 on NASDAQ.

What is the stated value of the planned AQST share sale for Daniel R. Barber?

The Form 144 lists an aggregate market value of 101000.00 for the planned sale of 25,000 AQST common shares. This value is tied to the proposed transaction to be executed on NASDAQ through Morgan Stanley Smith Barney LLC.

What is the origin of the 25,000 AQST shares being sold by Daniel R. Barber?

The 25,000 AQST shares originate from Restricted Stock Units acquired on 03/09/2024 from the issuer. The Form 144 identifies the security type as Restricted Stock Units and the acquisition source as the issuer.

What AQST stock transactions has Daniel R. Barber made in the past three months?

The filing shows two recent transactions labeled as 10b5-1 Sales: 25,000 shares of AQST common sold on 06/15/2026 for 104010.00, and 8,257 shares sold on 05/15/2026 for 35413.45.

Is Daniel R. Barber’s planned AQST sale under a Rule 10b5-1 trading arrangement?

Sales in the past three months are specifically labeled as 10b5-1 Sales in the filing. The planned Form 144 sale itself is listed alongside these disclosures, indicating a context that includes Rule 10b5-1 trading activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	101000.00	125450119	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2024	Restricted Stock Units	Issuer			25000	03/09/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL R BARBER 30 Technology Drive Warren NJ 07059	Common	06/15/2026	25000	104010.00
10b5-1 Sales for DANIEL R BARBER 30 Technology Drive Warren NJ 07059	Common	05/15/2026	8257	35413.45

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)